Literature DB >> 21954696

The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer.

Jonathan R Brody1, Agnieszka K Witkiewicz, Charles J Yeo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21954696     DOI： 10.1016/j.yasu.2011.04.002

Source DB:  PubMed          Journal:  Adv Surg        ISSN： 0065-3411


× No keyword cloud information.
  6 in total

1.  Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.

Authors:  Yehua Shen; Yan Pan; Litao Xu; Lianyu Chen; Luming Liu; Hao Chen; Zhen Chen; Zhiqiang Meng
Journal:  Tumour Biol       Date:  2015-02-27

Review 2.  Strategies for discovering novel pancreatic cancer biomarkers.

Authors:  Alison Chan; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  J Proteomics       Date:  2012-09-28       Impact factor: 4.044

3.  A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.

Authors:  Sukhwinder Kaur; Lynette M Smith; Asish Patel; Melanie Menning; Duncan C Watley; Saad S Malik; Shiv Ram Krishn; Kavita Mallya; Abhijit Aithal; Aaron R Sasson; Sonny L Johansson; Maneesh Jain; Shailender Singh; Sushovan Guha; Chandrakanth Are; Massimo Raimondo; Michael A Hollingsworth; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

4.  Utility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population.

Authors:  Dhavan A Parikh; Blythe Durbin-Johnson; Shiro Urayama
Journal:  J Gastrointest Cancer       Date:  2014-03

5.  Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer.

Authors:  Kelly E Henry; Travis M Shaffer; Kyeara N Mack; Janine Ring; Anuja Ogirala; Susanne Klein-Scory; Christina Eilert-Micus; Wolff Schmiegel; Thilo Bracht; Barbara Sitek; Marguerite Clyne; Colm J Reid; Bence Sipos; Jason S Lewis; Holger Kalthoff; Jan Grimm
Journal:  J Nucl Med       Date:  2021-03-12       Impact factor: 10.057

6.  The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma.

Authors:  Chun-Cheng Chiang; Chau-Ting Yeh; Tsann-Long Hwang; Yu-De Chu; Siew-Na Lim; Chun-Wei Chen; Chia-Jung Kuo; Puo-Hsien Le; Tsung-Hsing Chen; Wey-Ran Lin
Journal:  J Clin Med       Date:  2019-12-16       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.